Article Information
- Received September 5, 2007
- Revision received December 6, 2007
- Accepted December 10, 2007
- First published February 6, 2008.
- Version of record published February 6, 2008.
Author Information
- Verena Tretter1,2,
- Tija C. Jacob1,2,
- Jayanta Mukherjee1,
- Jean-Marc Fritschy3,
- Menelas N. Pangalos4, and
- Stephen J. Moss1,2
- 1Department of Neuroscience, University of Pennsylvania, Philadelphia, Pennsylvania 19104,
- 2Department of Pharmacology, University College London, London WC1E 6BT, United Kingdom,
- 3University of Zurich, Institute of Pharmacology and Toxicology, CH-8057 Zurich, Switzerland, and
- 4Wyeth Research, Neuroscience Discovery, Princeton, New Jersey 08852
- Correspondence should be addressed to Dr. Stephen J. Moss at the above address. sjmoss{at}mail.med.upenn.edu
Author contributions
Disclosures
- Received September 5, 2007.
- Revision received December 6, 2007.
- Accepted December 10, 2007.
-
This work was supported by a Marie Curie European Union postdoctoral fellowship to V.T. S.J.M. was supported by National Institutes of Health Grants NS 046478, 048045, 051195, and 056359, the Medical Research Council (U.K.), and the Wellcome Trust. We thank our former colleague Dr. Cecilia Gold for her helpful comments and unfailing support of this work. We thank Margie Maronski from the Dichter laboratory for preparation of cultured hippocampal neurons, John Raper (University of Pennsylvania) for the GFP-gephyrin construct, Yolande Haydon for manuscript preparation, Vann Bennett (Duke University) for the HA neurofascin, Margot Ernst (Medical University Vienna) for help with secondary structure predictions, and Karoline Fuchs (Medical University Vienna) for advice on molecular biology.
- Correspondence should be addressed to Dr. Stephen J. Moss at the above address. sjmoss{at}mail.med.upenn.edu
